Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials

INTRODUCTION: Even though increased use of reliever medication, including short-acting beta agonists (SABA), provides an indirect measure of symptom worsening, there have been limited efforts to assess how different patterns of reliever use correlate with symptom control and future risk of exacerbations. Here, we evaluate the effect of individual baseline characteristics on reliever use in patients with moderate-severe asthma on regular maintenance therapy with fluticasone propionate (FP) or combination therapy with fluticasone propionate/salmeterol (FP/SAL) or budesonide/formoterol (BUD/FOR).... Mehr ...

Verfasser: van Dijkman, Sven C
Yorgancıoğlu, Arzu
Pavord, Ian
Brusselle, Guy
Pitrez, Paulo M
Oosterholt, Sean
Fumali, Sourabh
Majumdar, Anurita
Della Pasqua, Oscar
Dokumenttyp: Artikel
Erscheinungsdatum: 2024
Verlag/Hrsg.: Springer Science and Business Media LLC
Schlagwörter: Asthma symptom control / Drug-disease modelling / Exacerbation / ICS/LABA combination therapy / Inhaled corticosteroids / Reliever medication / Rescue medication / SABA / Short-acting beta agonists
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29245406
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://discovery.ucl.ac.uk/id/eprint/10186844/1/s12325-023-02774-w.pdf